Skip to main content
Clinical Trials/JPRN-UMIN000018139
JPRN-UMIN000018139
Completed
未知

Effects on cardiac, renal, and vascular endothelial markers after switching to topiroxostat from febuxostat treatment among IGT patients - Effects on cardiac, renal, and vascular endothelial markers after switching to topiroxostat from febuxostat treatment among IGT patients

Diabetes and Lifestyle Center, Tomonaga Clinic0 sites100 target enrollmentJune 30, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Diabetes and Lifestyle Center, Tomonaga Clinic
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 30, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Diabetes and Lifestyle Center, Tomonaga Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who fall into any of the following conditions are excluded: 1\. Have a history of hypersensitiveness to topiroxostat, febuxostat, or allopurinol 2\. Currently on mercaptopurine hydrate (including those who plan to use) 3\. Currently on azathioprine (including those who plan to use) 4\. Cancer\-carrying (excepts for those completely cured) 5\. ALT or AST value is twice higher than the standard value set by each institution 6\. Complicated with chronic hepatitis (type B or C) and classified as active 7\. Complicated with hepatic cirrhosis 8\. Other conditions that may be judged by a (responsible) investigator to be inappropriate to this study

Outcomes

Primary Outcomes

Not specified

Similar Trials